Borderline Personality Disorder Clinical Trials in Halle
2 recruitingHalle, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder
Attention Deficit Hyperactivity DisorderBorderline Personality Disorder
Boehringer Ingelheim96 enrolled12 locationsNCT07001475
Recruiting
Phase 1Phase 2
Brain Signal Training to Enhance Affect Down-regulation
Borderline Personality Disorder
Central Institute of Mental Health, Mannheim164 enrolled6 locationsNCT06626789